Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.

Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, Tsang YT, Armaiz-Pena GN, Lu C, Kamat AA, Han LY, Spannuth WA, Nick AM, Landen CN, Wong KK, Gray MJ, Coleman RL, Bodurka DC, Brinkley WR, Sood AK. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res. 2008 Sep 01; 14(17):5437-46.

View in: PubMed

subject areas

Animals
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Cell Line, Tumor
Cell Proliferation
Cell Survival
Enzyme Inhibitors
Female
Humans
Mice
Ovarian Neoplasms
Piperazines
Taxoids
Xenograft Model Antitumor Assays

authors with profiles

Guillermo N Armaiz Pena

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support